Methotrexate Accord® infvlst 25mg en 100mg/ Hisun
Accord, als een van de snelstgroeiende generieke en biosimilaire bedrijven in Europa, neemt zijn
Read MoreAccord, als een van de snelstgroeiende generieke en biosimilaire bedrijven in Europa, neemt zijn
Read MoreIntas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses.
Read MoreAccord Healthcare launches Imatinib Accord 100 mg and 400 mg in the UK.
Read MoreIntas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland
Read MoreAccord Healthcare is delighted to announce the launch of Aripiprazole Accord, generic version of Abilify®. The product is available in 5, 10, 15 and 30 mg presentations in packs of 28 tablets.
Read MoreBurton-on-Trent, UK – 14 January 2014 - Clinigen Group plc (AIM: CLIN) today announced that its Clinical Trials Supply business (Clinigen CTS) has extended its exclusive European Union (EU) clinical trial distribution agreement with Accord Healthcare (‘Accord’), to include capecitabine, an orally administered chemotherapeutic tablet.
Read MoreBurton-on-Trent, UK – 20 June 2013 - Clinigen Group plc (‘Clinigen’ or the ‘Group’) (AIM: CLIN) today announced that Clinigen Clinical Trial Supply (‘CTS’) has extended its exclusive clinical trial distribution agreement with Accord Healthcare (‘Accord’), to supply clinical trials with Accord’s European injectable oncology drug portfolio for a further two years.
Read MoreA Judgment in the case was handed down by the Court of Appeal on the 30th of April and confirms the decision of the UK High Court in March 2012 that AstraZeneca’s patent is invalid, allowing Accord Healthcare UK to launch its generic version of Seroquel®.
Read More